Weighted Average Number of Shares Outstanding, Diluted of Galmed Pharmaceuticals Ltd. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Galmed Pharmaceuticals Ltd. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Galmed Pharmaceuticals Ltd. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 5,460,476, a 558% increase year-over-year.
  • Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 930,822, a 303% increase from 2023.
  • Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 230,795, a 65% increase from 2022.
  • Galmed Pharmaceuticals Ltd. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 139,682, a 91% decline from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

Galmed Pharmaceuticals Ltd. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 5,460,476 +4,630,976 +558% 01 Jul 2025 30 Sep 2025 6-K 26 Nov 2025 2025 Q3
Q2 2025 3,948,190 +3,270,329 +482% 01 Apr 2025 30 Jun 2025 6-K 28 Aug 2025 2025 Q2
Q3 2024 829,500 01 Jul 2024 30 Sep 2024 6-K 26 Nov 2025 2025 Q3
Q2 2024 677,861 -1,002,371 -60% 01 Apr 2024 30 Jun 2024 6-K 28 Aug 2025 2025 Q2
Q2 2023 1,680,232 +7,671 +0.46% 01 Apr 2023 30 Jun 2023 6-K 28 Aug 2024 2024 Q2
Q2 2022 1,672,561 -23,411,353 -93% 01 Apr 2022 30 Jun 2022 6-K 09 Aug 2023 2023 Q2
Q2 2021 25,083,914 01 Apr 2021 30 Jun 2021 6-K 04 Aug 2022 2022 Q2

Galmed Pharmaceuticals Ltd. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 930,822 +700,027 +303% 01 Jan 2024 31 Dec 2024 20-F 02 Apr 2025 2024 FY
2023 230,795 +91,113 +65% 01 Jan 2023 31 Dec 2023 20-F 02 Apr 2025 2024 FY
2022 139,682 -1,500,161 -91% 01 Jan 2022 31 Dec 2022 20-F 02 Apr 2025 2024 FY
2021 1,639,843 -19,640,944 -92% 01 Jan 2021 31 Dec 2021 20-F 04 Apr 2024 2023 FY
2020 21,280,787 +166,388 +0.79% 01 Jan 2020 31 Dec 2020 20-F 29 Mar 2023 2022 FY
2019 21,114,399 01 Jan 2019 31 Dec 2019 20-F 02 May 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.